Human immunodeficiency virus-negative plasmablastic lymphoma
Li Lin(Life Cycle Engineering (United States)), Qingjiang Chen(First Affiliated Hospital of Zhengzhou University), Yingjun Wang(South China University of Technology), Mingzhi Zhang(Chinese Academy of Sciences), Xinhua Wang(Zhengzhou University), Lei Zhang(Union Hospital), Meng Dong(First Affiliated Hospital of Zhengzhou University), Jingjing Wu(Zunyi Medical University), Xiaorui Fu(First Affiliated Hospital of Zhengzhou University), Yu Chang(Jilin University), Xudong Zhang(First Affiliated Hospital of Zhengzhou University), Ling Li(First Affiliated Hospital of Zhengzhou University), Zhi‐Yuan Zhou(Tsinghua University), Zhenchang Sun(First Affiliated Hospital of Zhengzhou University), Zhaoming Li(First Affiliated Hospital of Zhengzhou University)
Cited by 18
Related Papers
PD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response?
|Frontiers in Immunology|2017|296
Acalabrutinib (ACP-196): a selective second-generation BTK inhibitor
|Journal of Hematology & Oncology|2016|250
Latent tuberculosis infection in rural China: baseline results of a population-based, multicentre, prospective cohort study
|The Lancet Infectious Diseases|2015|231
Altermagnets as a new class of functional materials
|Nature Reviews Materials|2025|200
miR-137 Is Frequently Down-Regulated in Gastric Cancer and Is a Negative Regulator of Cdc42
|Digestive Diseases and Sciences|2011|140